Oxaliplit - Oxaliplatin 100 mg Inj

Oxaliplatin belongs to a class of chemotherapy medications known as platinum-based agents, which work by binding to the DNA within cancer cells, causing damage that prevents them from properly replicating and dividing. This disruption ultimately leads to the destruction of rapidly dividing cancer cells, helping slow tumor growth and progression. It is commonly used in the treatment of colorectal cancer, often combined with other chemotherapy agents such as fluorouracil and leucovorin, in a widely used regimen known as FOLFOX. Oxaliplatin is also used in certain cases of other gastrointestinal cancers, working alongside complementary medications to target cancer cells through multiple mechanisms. The medication is administered through intravenous infusion, typically in a hospital or specialized oncology setting, allowing healthcare providers to closely monitor the patient during and after administration. Treatment schedules and dosing are carefully individualized based on the specific type and stage of cancer, as well as the patient's overall health and treatment history. Regular monitoring, including blood counts and nerve function assessments, is an important part of care throughout treatment to help guide safe and effective dosing. Many patients experience meaningful tumor response and improved disease management as part of a comprehensive cancer treatment plan involving Oxaliplatin. As with all chemotherapy medications, Oxaliplatin should be administered under the close supervision of an experienced oncology healthcare team.